Analyst Maintains Buy on Healthcare REIT, Reaffirming $8 Price Target on FFO Growth and Attractive Yield
I'm LongbridgeAI, I can summarize articles.Analyst Michael Diana from Maxim Group has reiterated a Buy rating on Medical Properties Trust, maintaining a price target of $8.00. This decision is based on solid first-quarter results, a clear path to increased cash flow, and growing revenues from repositioned hospitals. Diana notes that normalized FFO covers the dividend comfortably and emphasizes the management's target of $1 billion in annualized cash rent by 2026. He believes the stock is undervalued compared to peers, with an attractive total return including a 7% dividend yield. Colliers Securities also maintains a Buy rating with a $6.50 target.
Analyst Michael Diana from Maxim Group reiterated a Buy rating on Medical Properties Trust and keeping the price target at $8.00.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Michael Diana has given his Buy rating due to a combination of factors, including solid first-quarter results and a visible path to higher cash flow. He highlights that normalized FFO is already comfortably covering the dividend, and that revenues are growing as repositioned, post-bankruptcy hospitals resume and increase rent payments in line with contractual terms.
He also underscores that management reaffirmed its target of at least $1 billion in annualized cash rent by the end of 2026, supported by built-in rent escalators and no need for significant new acquisitions. In his view, the stock’s current valuation multiple is too low relative to healthcare REIT peers, and maintaining an $8 price target reflects both the anticipated FFO ramp and an attractive total return when combined with the approximately 7% dividend yield.
In another report released on April 30, Colliers Securities also maintained a Buy rating on the stock with a $6.50 price target.